Annual FCF
-$18.77 M
-$39.25 M-191.63%
31 December 2023
Summary:
Pharming Group NV annual free cash flow is currently -$18.77 million, with the most recent change of -$39.25 million (-191.63%) on 31 December 2023. During the last 3 years, it has fallen by -$87.09 million (-127.47%). PHAR annual FCF is now -127.47% below its all-time high of $68.33 million, reached on 31 December 2020.PHAR Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$9.38 M
+$22.81 M+169.79%
30 September 2024
Summary:
Pharming Group NV quarterly free cash flow is currently $9.38 million, with the most recent change of +$22.81 million (+169.79%) on 30 September 2024. Over the past year, it has increased by +$6.00 million (+177.40%). PHAR quarterly FCF is now -71.12% below its all-time high of $32.47 million, reached on 31 December 2017.PHAR Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$540.00 K
+$6.00 M+91.74%
30 September 2024
Summary:
Pharming Group NV TTM free cash flow is currently -$540.00 thousand, with the most recent change of +$6.00 million (+91.74%) on 30 September 2024. Over the past year, it has increased by +$24.55 million (+97.85%). PHAR TTM FCF is now -100.75% below its all-time high of $72.20 million, reached on 30 September 2020.PHAR TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAR Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -191.6% | +177.4% | +97.8% |
| 3 y3 years | -127.5% | +256.8% | -102.0% |
| 5 y5 years | -144.7% | +160.5% | -101.2% |
PHAR Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -127.5% | at low | -25.1% | +140.8% | -102.0% | +97.8% |
| 5 y | 5 years | -127.5% | at low | -54.4% | +140.8% | -100.8% | +97.8% |
| alltime | all time | -127.5% | +36.5% | -71.1% | +140.8% | -100.8% | +98.5% |
Pharming Group NV Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $9.38 M(-169.8%) | -$540.00 K(-91.7%) |
| June 2024 | - | -$13.44 M(+73.9%) | -$6.54 M(+87.1%) |
| Mar 2024 | - | -$7.73 M(-168.7%) | -$3.49 M(-81.4%) |
| Dec 2023 | -$18.77 M(-191.6%) | $11.25 M(+232.7%) | -$18.77 M(-25.2%) |
| Sept 2023 | - | $3.38 M(-132.5%) | -$25.09 M(+57.2%) |
| June 2023 | - | -$10.39 M(-54.8%) | -$15.96 M(+479.7%) |
| Mar 2023 | - | -$23.00 M(-567.5%) | -$2.75 M(-113.4%) |
| Dec 2022 | $20.48 M(-3.1%) | $4.92 M(-60.7%) | $20.48 M(-19.3%) |
| Sept 2022 | - | $12.51 M(+344.5%) | $25.37 M(+63.8%) |
| June 2022 | - | $2.81 M(+1103.0%) | $15.48 M(-10.3%) |
| Mar 2022 | - | $234.00 K(-97.6%) | $17.26 M(-18.3%) |
| Dec 2021 | $21.13 M(-69.1%) | $9.80 M(+273.1%) | $21.13 M(-20.6%) |
| Sept 2021 | - | $2.63 M(-42.8%) | $26.61 M(-36.1%) |
| June 2021 | - | $4.59 M(+12.1%) | $41.66 M(-27.7%) |
| Mar 2021 | - | $4.10 M(-73.2%) | $57.62 M(-15.7%) |
| Dec 2020 | $68.33 M(+40.3%) | $15.29 M(-13.5%) | $68.33 M(-5.4%) |
| Sept 2020 | - | $17.68 M(-14.0%) | $72.20 M(+24.2%) |
| June 2020 | - | $20.55 M(+38.8%) | $58.12 M(+9.9%) |
| Mar 2020 | - | $14.80 M(-22.7%) | $52.87 M(+8.6%) |
| Dec 2019 | $48.70 M(+15.9%) | $19.16 M(+432.4%) | $48.70 M(+6.3%) |
| Sept 2019 | - | $3.60 M(-76.5%) | $45.83 M(-22.6%) |
| June 2019 | - | $15.30 M(+43.9%) | $59.23 M(+7.9%) |
| Mar 2019 | - | $10.63 M(-34.8%) | $54.92 M(+30.7%) |
| Dec 2018 | $42.03 M(+8.9%) | $16.30 M(-4.1%) | $42.03 M(-27.8%) |
| Sept 2018 | - | $17.00 M(+54.7%) | $58.19 M(+6.8%) |
| June 2018 | - | $10.99 M(-586.8%) | $54.47 M(+28.2%) |
| Mar 2018 | - | -$2.26 M(-107.0%) | $42.49 M(+10.1%) |
| Dec 2017 | $38.59 M | $32.47 M(+144.7%) | $38.59 M(+352.5%) |
| Sept 2017 | - | $13.27 M(-1443.6%) | $8.53 M(-196.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | -$987.60 K(-84.0%) | -$8.87 M(-39.6%) |
| Mar 2017 | - | -$6.16 M(-356.1%) | -$14.67 M(+21.1%) |
| Dec 2016 | -$12.11 M(-38.4%) | $2.40 M(-158.3%) | -$12.11 M(-33.7%) |
| Sept 2016 | - | -$4.13 M(-39.2%) | -$18.28 M(-4.6%) |
| June 2016 | - | -$6.79 M(+88.6%) | -$19.16 M(+4.2%) |
| Mar 2016 | - | -$3.60 M(-4.2%) | -$18.39 M(-6.5%) |
| Dec 2015 | -$19.68 M(+493.4%) | -$3.76 M(-24.9%) | -$19.68 M(+1069.7%) |
| Sept 2015 | - | -$5.00 M(-16.9%) | -$1.68 M(-271.7%) |
| June 2015 | - | -$6.02 M(+23.2%) | $980.00 K(-156.2%) |
| Mar 2015 | - | -$4.89 M(-134.3%) | -$1.75 M(-44.2%) |
| Dec 2014 | -$3.32 M(-77.0%) | $14.23 M(-707.6%) | -$3.13 M(-59.7%) |
| Sept 2014 | - | -$2.34 M(-73.2%) | -$7.76 M(+45.8%) |
| June 2014 | - | -$8.75 M(+39.5%) | -$5.32 M(+92.7%) |
| Mar 2014 | - | -$6.27 M(-165.3%) | -$2.76 M(+9425.2%) |
| Dec 2013 | - | $9.60 M(+9797.2%) | -$29.00 K(-99.6%) |
| Sept 2013 | - | $97.00 K(-101.6%) | -$8.28 M(-36.5%) |
| June 2013 | - | -$6.19 M(+74.8%) | -$13.03 M(-0.9%) |
| Mar 2013 | - | -$3.54 M(-362.1%) | -$13.14 M(-8.7%) |
| Dec 2012 | -$14.39 M(-38.3%) | $1.35 M(-129.0%) | -$14.39 M(-58.8%) |
| Sept 2012 | - | -$4.66 M(-26.1%) | -$34.95 M(+4.0%) |
| June 2012 | - | -$6.30 M(+31.5%) | -$33.60 M(+23.1%) |
| Mar 2012 | - | -$4.79 M(-75.1%) | -$27.30 M(+21.3%) |
| Dec 2011 | -$23.31 M(-21.2%) | -$19.20 M(+480.3%) | -$22.51 M(+580.3%) |
| Sept 2011 | - | -$3.31 M(-117.7%) | -$3.31 M(+622.0%) |
| Sept 2009 | - | $18.74 M(-275.6%) | -$458.30 K(-97.6%) |
| June 2009 | - | -$10.67 M(+25.2%) | -$19.20 M(+125.2%) |
| Mar 2009 | - | -$8.53 M | -$8.53 M |
| Dec 2006 | -$29.58 M(+81.7%) | - | - |
| Dec 2005 | -$16.28 M | - | - |
FAQ
- What is Pharming Group NV annual free cash flow?
- What is the all time high annual FCF for Pharming Group NV?
- What is Pharming Group NV annual FCF year-on-year change?
- What is Pharming Group NV quarterly free cash flow?
- What is the all time high quarterly FCF for Pharming Group NV?
- What is Pharming Group NV quarterly FCF year-on-year change?
- What is Pharming Group NV TTM free cash flow?
- What is the all time high TTM FCF for Pharming Group NV?
- What is Pharming Group NV TTM FCF year-on-year change?
What is Pharming Group NV annual free cash flow?
The current annual FCF of PHAR is -$18.77 M
What is the all time high annual FCF for Pharming Group NV?
Pharming Group NV all-time high annual free cash flow is $68.33 M
What is Pharming Group NV annual FCF year-on-year change?
Over the past year, PHAR annual free cash flow has changed by -$39.25 M (-191.63%)
What is Pharming Group NV quarterly free cash flow?
The current quarterly FCF of PHAR is $9.38 M
What is the all time high quarterly FCF for Pharming Group NV?
Pharming Group NV all-time high quarterly free cash flow is $32.47 M
What is Pharming Group NV quarterly FCF year-on-year change?
Over the past year, PHAR quarterly free cash flow has changed by +$6.00 M (+177.40%)
What is Pharming Group NV TTM free cash flow?
The current TTM FCF of PHAR is -$540.00 K
What is the all time high TTM FCF for Pharming Group NV?
Pharming Group NV all-time high TTM free cash flow is $72.20 M
What is Pharming Group NV TTM FCF year-on-year change?
Over the past year, PHAR TTM free cash flow has changed by +$24.55 M (+97.85%)